Hide Board Information

Show Board Information

TetraLogic Pharmaceuticals Corporation / NASDAQ: TLOG

Board Mod: mick

Asst Mods:

Last Post: 04/13/2017 11:31:35 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

TetraLogic Pharmaceuticals TLOG is a clinical-stage biopharmaceutical company focused on discovering, acquiring and
developing novel product candidates to treat cancer and infectious diseases

http://tetralogicpharma.com/about-us/

TetraLogic Pharmaceuticals Corporation / NASDAQ: (NASDAQ: TLOG) Stock Message Board

1. TLOG Company Profile

    

2. TLOG Time & Sales

    

3. TLOG Recent News

    

4. TLOG Filings

    

5. TLOG Financials

    

6. TLOG Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

5	WRONG STUFF	mick	04/13/2017 11:31:35 AM
4	$TLOG 0.0486 +0.0049 +11.09% 58,612 Chart, News,	mick	04/05/2017 3:21:15 PM
3	$TLOG/ Recent CandleStick Analysis, Very Bullish	mick	04/01/2017 11:17:25 AM
2	the body of board will not show, quote and other	mick	03/17/2017 11:15:28 AM
1	$TLOG/ this new here but can be nice	mick	03/17/2017 10:43:54 AM

Recent Articles

• Legal Investigations Alert: Shareholder Rights and Actions
• NOVONIX Set to Shine at December Investor Engagements
• Montfort Capital Reports Q3 Financials and Divestment Plan
• Understanding Distribution Sources of Cohen & Steers Fund (RNP)
• Exploring the Innovative Landscape of Cannabis with High Science
• Understanding Cohen & Steers Total Return Realty Fund Distributions
• Investment Insights from Cohen & Steers Opportunity Fund
• Xerox Holdings Corporation: Investigating Investor Claims and Losses
• Investigation Notice: Humacyte Investors Should Act Now
• Fusion Fuel's Strategic Acquisition and Leadership Transition
• Rivalry Corp. Announces Successful Non-Brokered Placement Raise
• Cohen & Steers Infrastructure Fund Updates Distribution Insights
• Growth Surge in Voice Evacuation Systems: A 1.1 Billion Leap
• FIBRA Prologis Completes Tender Offer for Terrafina CBFIs
• Understanding Distribution Sources for Cohen & Steers Realty Fund
• Marpai Secures New Clients and Prepares for 2025 Growth
• Lumina Gold's New Exploitation Contract Marks a Milestone
• Goldman Sachs Shares Hedging Strategies for 2025 Market Risks
• WattEV Advances EV Charging with New Rapid-Charging Standards
• DIRTT Environmental Solutions Welcomes Holly Hess Groos
• Mondee Faces Nasdaq Compliance Challenge Amid Leadership Changes
• Teamsters Union Grows as FreshPoint Drivers Take a Stand
• Challenges of Cannabis Legalization: Insights from Berlin's Justice Senator
• TerrAscend Elevates Lynn Gefen to Chief People Officer Role
• Maximus Inc Faces Uncertainty After Contract Cancellation
• Kentucky's New Medical Cannabis Licenses Create Excitement
• Franklin Templeton Updates Investors on ETF Liquidation Plans
• Peoples Financial Corporation Announces Cash and Special Dividends
• Lilium N.V. Investors: Key Opportunities in Lawsuit Leadership
• S&W Seed Company Releases First Quarter 2025 Financials
• Pond Technologies Expands Market Reach with Q3 Financial Filing
• HP Inc. Reports Robust Q4 Results Amidst Stock Fluctuation
• Gran Tierra Energy's New Oil Discovery and Strategic Partnership
• Transforming the Events Industry: Rhuna Partners with Plume
• ANI Pharmaceuticals Prepares for Piper Sandler Healthcare Conference
• Ultragenyx Pharmaceutical's Upcoming Investor Conferences in December
• Exela Technologies Outlines Plans for Upcoming Earnings Call
• Cansortium Expands Financial Flexibility with New Credit Deal
• Aclaris Therapeutics to Showcase Innovations at Major Conference
• YXT.com Unveils Key Leadership Changes to Drive Growth
• Mazarin Inc. Welcomes New CFO Amid Strategic Changes
• Mazarin Inc. Grants Stock Options to Enhance Share Value
• Autodesk Delivers Impressive Q3 Earnings Report
• Nutanix Reports Strong Q1 Earnings Performance and Growth
• Urbanfund Corp. Reports Impressive Financial Performance
• Ambarella Inc Achieves Impressive Q3 Results, Stock Rises
• Yelp Acquires RepairPal for Strategic Expansion in Services
• TechTarget's Merger with Informa: A Game-Changer in B2B
• Onco360 Partners with BrightSpring for Innovative Cancer Therapies
• How Tariff Policies Shape Global Currencies and Markets